[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
July 1982

Chemotherapy Before and After Mastectomy in Stage III Breast Cancer

Author Affiliations

From the Departments of Neoplastic Diseases (Dr Perloff and Surgery (Dr Lesnick), Mount Sinai School of Medicine, New York. Dr Perloff is now with Columbia University College of Physicians and Surgeons, New York.

Arch Surg. 1982;117(7):879-881. doi:10.1001/archsurg.1982.01380310005002

• Seventeen patients with stage III breast cancer were treated by modified radical mastectomy preceded and followed by multiagent cytotoxic chemotherapy. The preoperative treatment resulted in a decrease in size of the primary tumor, facilitating the subsequent surgical procedure. There were no serious surgical complications. Wound healing was uneventful. Median disease-free survival time was 29 months and median survival time was 40+ months. Six of the 17 patients are living free of recurrence from more than 33 to more than 79 months after initial therapy.

(Arch Surg 1982;117:879-881)

Haagensen CD, Stout AP:  Carcinoma of the breast: II. Criteria of operability . Ann Surg 1943;118:859.Article
Baclesse S:  Roentgen therapy as the sole method of treatment of cancer of the breast . AJR 1949;62:311-319.
Bruckman JU, Harris JR, Levene MB, et al:  Results of treating stage III carcinoma of the breast by primary radiation therapy . Cancer 1979;43:985-993.Article
Zucali R, Uslenghi C, Kenda R, et al:  Natural history and survival of inoperable breast cancer treated with radiotherapy or radiotherapy followed by radical mastectomy . Cancer 1976;37:1422-1431.Article
Arnold DJ, Lesnick GJ:  Survival following mastectomy for stage III breast cancer . Am J Surg 1979;137:362-366.Article
Perloff M, Holland JF, Lumb GJ, et al:  Effects of methanol extraction residue of bacillus Calmette-Guerin in humans . Cancer Res 1977;37:1191-1196.
Sponzo RW, Cunningham TJ, Caradonna RR:  Management of non-resectable (stage III) breast cancer . J Radiation Oncol Biol Phys 1979;5:1475-1478.Article
De Lena M, Zucali R, Varini M, et al:  Combined modality approach in locally advanced breast cancer . Proc Am Assoc Cancer Res 1979;20:172.
Osteen RC, Chaffey JP, Moore SD, et al:  An aggressive multimodality approach to locally advanced carcinoma of the breast . Surg Gynecol Obstet 1978;147:75-79.
Olivari AJ, Glait HM, Varela OA, et al:  Six years follow-up in levamisole treated stage III breast cancer patients . Proc Am Assoc Cancer Res 1980;21:362.
Rubens RO, Sexton S, Tong D, et al:  Combined chemotherapy and radiotherapy for locally advanced breast cancer . Eur J Cancer 1980;16:351-356.Article